Benjamin Besse
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Benjamin Besse
Sep 19, 2024, 16:38 |
Blog
Benjamin Besse: Impressive benefit for Lenvatinib-Pembrolizumab in patients with thymic carcinoma and B3 thymoma
Estela Rodriguez shared a post by Benjamin Besse, Head of Clinical Research at Gustave Roussy,…
Sep 19, 2024, 09:23 |
Insight
Jessica Lin: Preclinical development and proof-of-concept clinical activity of NVL-655
Jessica Lin shared a post on LinkedIn: "We are pleased to share this article out today…
Sep 17, 2024, 15:07 |
Blog
Stephen V Liu: Data from ARROS-1 study of NVL-520 in ROS1 NSCLC
Stephen V Liu shared a post on X: ''Benjamin Besse presents data from ARROS-1 study…
Sep 15, 2024, 16:26 |
Societies
43 Posts Not To Miss From ESMO24 Day 2
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 14, 2024, 15:40 |
Insight
Key Findings from the PECATI Trial at ESMO 2024
The results of the PECATI trial were recently presented at ESMO 2024. The PECATI trial…
Sep 7, 2024, 07:32 |
Insight
5 papers about lung cancer suggested by Stephen Liu
Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…
Aug 9, 2024, 01:47 |
Insight
5 papers about Lung Cancer suggested by Stephen Liu
Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…
Aug 5, 2024, 01:55 |
Societies
Scientific Committees at the ESMO Congress 2024
The ESMO Congress is a globally influential oncology platform that brings together clinicians, researchers, patient…
Jul 3, 2024, 17:29 |
Blog
Benjamin Besse: Stop pembro after 2 years?
Benjamin Besse, Head of Clinical Research at Gustave Roussy, shared on X: "Stop pembro after…
Jun 28, 2024, 04:59 |
Blog
Mihaela Aldea received a 2024 IASLC YIA
Mihaela Aldea, Medical Oncologist at the Gustave Roussy, shared a post on X: "Honored to…
Jun 27, 2024, 14:15 |
Blog
David Planchard: Nice post-ASCO24 at Gustave Roussy with the lung session
David Planchard shared on LinkedIn: "Nice post-ASCO24 Gustave Roussy with the lung session. What wonderful…
Jun 10, 2024, 13:02 |
Blog
Lung Cancer Europe has two valuable webinars coming up in June and July
Lung Cancer Europe shared on X/Twitter: "Lung Cancer Europe (LuCE) has two valuable webinars coming up…
May 25, 2024, 05:54 |
Blog
Patrizia Giannatempo: Thanks, ESMO for the opportunity to discuss the landmark EV-302 paper
Patrizia Giannatempo, Medical Oncologist at IRCCS National Cancer Institute Foundation, shared on X: "Thanks, ESMO…
May 24, 2024, 13:02 |
Blog
Jose Carlos Benitez: Thrilled to have organized the EORTC LCG spring meeting at home Ayuntamiento de Málaga
Jose Carlos Benitez, Medical Oncologist at University Hospital Virgen de la Victoria, shared a post on…
May 23, 2024, 14:25 |
Insight
Benjamin Besse: Should we infuse IO in the morning?
Benjamin Besse, Head of Clinical Research on Gustave Roussy, shared on X: "Should we infuse…
May 18, 2024, 00:16 |
Blog
Luis E. Raez: Analysis of PRO data from the landmark LIBRETTO-001 trial
Luis E. Raez, Medical Director at Memorial Cancer Institute, shared a post on X: "In this…
May 12, 2024, 13:30 |
Blog
Biagio Ricciuti: Insightful discussions at Rome Lung 24
Biagio Ricciuti shared a post by Stephen Liu on X and added: "Had a great…
Apr 18, 2024, 16:36 |
Insight
New Paper Alert! Understanding the Effects of Post-irAE Treatments With Immunosuppressant Agents in Cancer Immunotherapy
Understanding the Effects of Post-irAE Treatments With Immunosuppressant Agents in Cancer Immunotherapy Authors: Pierre-Louis Cariou,…
Apr 17, 2024, 10:09 |
Positive
Yaniss B.: The 3rd edition of the Transatlantic Exchanges in Oncology was a huge success!
Yaniss B, Valorisation Officer at Gustave Roussy Transfert shared on X: “The 3rd edition of the…
Apr 9, 2024, 09:03 |
Insight
Giannis Mountzios: The value of post-marketing pragmatic re-assessment of new TKIs in NSCLC
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General…
Mar 21, 2024, 15:19 |
Blog
Jarushka Naidoo: Getting ready to plan ASCO24
Jarushka Naidoo shared a post on X/Twitter: “Getting ready to plan ASCO24! And with a…
Sep 12, 2023, 20:05 |
Insight
Benjamin Besse: Time to change our practice and give our IOs in the morning?
Benjamin Besse, Head of Clinical Research at Gustave Roussy, shared on Twitter: "Accumulative publications showing…
All:
22
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube